Skip to main content
P

Precision Biosensor Inc. — Investor Relations & Filings

Ticker · 335810 ISIN · KR7335810008 KO Manufacturing
Open in API
Filings indexed 172 across all filing types
Latest filing 2026-03-25 Declaration of Voting R…
Country KR South Korea
Listing KO 335810

About Precision Biosensor Inc.

https://precision-bio.com/

Precision Biosensor Inc. is an in vitro diagnostics (IVD) company that develops, manufactures, and commercializes clinical diagnostic solutions. The company specializes in point-of-care testing (POCT), providing optimized systems for on-site diagnosis. Its product portfolio includes analyzing devices and diagnostic reagents for both human and animal health. Precision Biosensor utilizes advanced technologies, such as time-resolved fluorescence (TRF), for the sensitive and accurate detection of various disease biomarkers in immuno-diagnosis and clinical chemistry applications, including cardiac markers.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement of the results of the 2026 Annual General Meeting (“정기주주총회 결과”), listing each agenda item, its approval status (가결), and voting percentages. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-25 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Precision Bioscience (프리시젼바이오) for the fiscal year ending December 31, 2025. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial data, it is specifically an audit report issued by an accounting firm (Samduk Accounting Corp) rather than a company-issued 10-K or quarterly report. According to the provided definitions, standalone audit reports and results of internal/regulatory assessments fall under the 'Audit Report / Information' (AR) category. FY 2025
2026-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Precision Bioscience. It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a specific regulatory disclosure of the audit results rather than the full 10-K annual report itself. In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information document. FY 2025
2026-03-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (Precision Biosensor) regarding a significant change in financial structure (revenue or profit/loss fluctuation of 30% or more). This is a standard disclosure requirement for companies listed on the KRX (Korea Exchange). Since it provides specific financial highlights and performance data rather than just announcing the availability of a report, it falls under the category of a general regulatory filing/announcement.
2026-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Precision Bio. It contains the meeting agenda, date, location, and detailed management information regarding board activities, remuneration, and business operations (Management Report/Business Overview). This type of document is standard for providing shareholders with the necessary information to vote at an upcoming Annual General Meeting. According to the provided definitions, this falls under Proxy Solicitation & Information Statement (PSI) as it provides information and requests votes for the meeting.
2026-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Precision Bio. It outlines the date, location, and specific agenda items (financial statements, articles of incorporation changes, and director/auditor compensation) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2026-03-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.